Value of Single‐Photon Emission‐Computed Tomography in Acute Stroke Therapeutic Trials
暂无分享,去创建一个
[1] F. Mahoney,et al. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.
[2] G. Donnan,et al. Reperfusion After Thrombolytic Therapy in Ischemic Stroke Measured by Single‐Photon Emission Computed Tomography , 1994, Stroke.
[3] S. Davis,et al. Cerebral Hypoperfusion in Stroke Prognosis and Brain Recovery , 1993, Stroke.
[4] T. Olsen,et al. Thrombolytic Therapy In Acute Ischemic Stroke: A Danish Pilot Study , 1993, Stroke.
[5] G. Marchal,et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.
[6] Jeffrey Hill. Randomized, double-blind, placebo-controlled trial of nimodipine in acute stroke , 1991 .
[7] M. Limburg,et al. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF‐SPECT , 1991, Acta neurologica Scandinavica.
[8] M. Limburg,et al. rCBF-SPECT in brain infarction: when does it predict outcome? , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] M. Limburg,et al. Single-photon emission computed tomography and early death in acute ischemic stroke. , 1990, Stroke.
[10] C. Pozzilli,et al. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. , 1990, Stroke.
[11] S. Sakuma,et al. Role of Fast Data Acquisition Method with Tc‐99m HMPAO Brain SPECT in Patients with Acute Stroke , 1990, Clinical nuclear medicine.
[12] D. Perani,et al. Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomography. , 1989, Archives of neurology.
[13] J. Marler,et al. Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.
[14] G. Lenzi,et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours , 1989, Journal of the Neurological Sciences.
[15] D. Bushnell,et al. Prediction of language and neurologic recovery after cerebral infarction with SPECT imaging using N-isopropyl-p-(I 123) iodoamphetamine. , 1989, Archives of neurology.
[16] D. Gur,et al. Cerebral blood flow determination within the first 8 hours of cerebral infarction using stable xenon-enhanced computed tomography. , 1989, Stroke.
[17] James N. Davis,et al. Interrater reliability of the NIH stroke scale. , 1989, Archives of neurology.
[18] L. Hayman,et al. Cerebral infarction: diagnosis and assessment of prognosis by using 123IMP-SPECT and CT. , 1989, AJNR. American journal of neuroradiology.
[19] J. Baron,et al. SPECT analysis of recent cerebral infarction. , 1989, Stroke.
[20] W Lang,et al. Initial experience with technetium-99m HM-PAO brain SPECT. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] D. Nowotnik,et al. Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] D. O'leary,et al. Predictive value of perfusion defect size using N-isopropyl-(I-123)-p-iodoamphetamine emission tomography in acute stroke. , 1984, Journal of neurosurgery.
[23] H. L. Bleich,et al. The Harvard Cooperative Stroke Registry , 1978, Neurology.
[24] J. Mountz,et al. Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. , 1990, Journal of Nuclear Medicine.
[25] J. Baron,et al. Pathophysiologic study of chronic infarcts with I-123 isopropyl iodo-amphetamine (IMP): the importance of periinfarct area. , 1987, Stroke.